CD44 and ovarian cancer: CD44v6 is one of the most common variants of CD44, and some meta-analyses have shown that the expression of CD44v6 is related to a poor prognosis in gastric and hepatocellular carcinomas (60, 61) but is not related to prognosis in ovarian cancer (20).